AI-generated content for informational purposes only. Not financial advice. Always do your own research.

概要

UnitedHealth Group (NYSE: UNH)は売上高で世界最大のヘルスケア企業であり、時価総額で最も価値のあるヘルス株であり、2つの主要部門を通じて運営されています。UnitedHealthcareは国内最大のヘルス保険プロバイダーで、5,000万人以上のメンバーをカバーしており、Optumは薬学的給付、医療提供、およびデータ分析に広がる多様なヘルスサービス事業です。Optumセグメントは重要な成長エンジンであり、医師プラクティス、外来手術センター、在宅医療サービスを通じた直接ヘルスケア提供に拡大し、垂直統合ヘルスケア企業を創出しています。UnitedHealth Groupは支配的なヘルスケア投資であり、ヘルスサービスの全スペクトラムへのエクスポーザー、実証済みの経営チーム、一貫した二桁の利益成長、10年以上にわたる配当増加の実績を提供します。

高齢化関連株

UnitedHealth Groupは世界最大の医療企業であり、米国最大の健康保険会社(UnitedHealthcare)とOptumの医療サービスを組み合わせ、高齢化人口動態の恩恵を直接受けています。

ヘルスケア株

UnitedHealth Groupは、売上高と時価総額の両方で最大の医療銘柄であり、米国最大の健康保険事業と急成長するOptumヘルスサービスプラットフォームを組み合わせ、米国医療システムのほぼあらゆる側面に関わる垂直統合型の医療企業を形成しています。

Key Financials UNH

価格 $293.19
変動(1日) +3.10%
変動 (30D) -11.18%
変動 (60D) -8.53%
変動 (90D) -18.28%
変動 (180D) -1.65%
変動 (1Y) -44.41%
変動 (5Y) -11.05%
P/E比 13.20
EPS (TTM) $22.21
52週レンジ $234.60 — $606.36
50日MA $321.23
出来高 10.27M

Data updated Feb 15 · Source: Twelve Data

4.1
2 reviews
Demographic Exposure
4.7
Growth Potential
3.8
Dividend Reliability
3.5
Financial Stability
3.2
Regulatory Risk
2
Claude Opus 4.6
AI Review
3.7/5

UnitedHealth Group, the nation's largest health insurer and parent of Optum's healthcare services empire, has experienced a dramatic decline " down over 44% in the past year from its 52-week high of $606. The sell-off reflects a convergence of headwinds: rising medical costs, regulatory scrutiny, a DOJ investigation, and the tragic shooting of a subsidiary CEO that intensified public backlash against managed care. At a P/E of 13.2x with EPS of $22.21, the stock trades at a significant discount to historical multiples, potentially offering deep value for patient investors. The bull case centers on UNH's dominant market position in Medicare Advantage (directly benefiting from aging demographics), diversified revenue streams through Optum, and a track record of consistent earnings growth. The bear case includes elevated medical loss ratios, political risk around healthcare reform, potential regulatory actions, and questions about whether management can restore credibility. Trading well below its 50-day moving average of $321, momentum remains decidedly negative. However, UNH's structural advantages in serving an aging population and its integrated care model provide a durable competitive moat that makes this selloff worth monitoring closely.

Demographic Exposure
4.7
Growth Potential
3.8
Dividend Reliability
3.5
Financial Stability
3.2
Regulatory Risk
2
Feb 15, 2026
Gemini 3 Pro Preview
AI Review
4.4/5

UnitedHealth Group remains a dominant force in the healthcare sector, leveraging its integrated model of insurance (UnitedHealthcare) and health services (Optum) to drive long-term growth. The provided financial data indicates the stock is currently trading at a P/E ratio of 12.30, a valuation that appears remarkably attractive relative to historical norms for such a high-quality compounder. While the share price has retreated significantly from its 52-week high of $606.36, creating a bearish technical setup below the 50-day moving average, the company's earnings power remains resilient with an EPS of $22.21. Investors must weigh the attractive valuation against risks like regulatory scrutiny on Medicare Advantage and rising medical loss ratios. However, for value-oriented investors, UNH presents a potential opportunity to acquire a sector leader at a discounted multiple.

Feb 11, 2026
UnitedHealth Group Screenshot

Added: Feb 10, 2026

unitedhealthgroup.com

Latest from Otrai

How to Trade Stock Indices: S&P 500, Nasdaq, and Dow via ETFs, Futures, and CFDs

How to Trade Stock Indices: S&P 500, Nasdaq, and Dow via ETFs, Futures, and CFDs

A stock index is a single number that summarizes the price action of a basket of companies. The S&P 500 tracks roughly 500 large US firms, the Nasdaq-100 tracks the 100 largest non-financial names on the Nasdaq exchange, and the Dow Jones Industrial Average follows 30 blue-chip stocks.

The Options Greeks Explained: Delta, Gamma, Theta, and Vega

The Options Greeks Explained: Delta, Gamma, Theta, and Vega

The Greeks explain why an option costs what it costs and how that price changes when the stock moves, time passes, and volatility shifts. Delta, Gamma, Theta, and Vega, made accessible.

Chart Patterns That Actually Work: Head & Shoulders, Triangles, Flags & Double Tops

Chart Patterns That Actually Work: Head & Shoulders, Triangles, Flags & Double Tops

Chart patterns are the most recognizable part of technical analysis and the most misunderstood. Most fail or break out the wrong way before reversing. This guide covers head and shoulders, double tops and bottoms, triangles, and flags — with realistic reliability, target measurement, and false-breakout confirmation.

取引戦略のバックテスト方法:手法、落とし穴、結果が実際に何を意味するのか

取引戦略のバックテスト方法:手法、落とし穴、結果が実際に何を意味するのか

すべてのトレーダーは頭の中で良さそうに見える戦略を持っています。バックテストは、それが実際に機能するかどうかを調べる方法です。ここは戦略を適切にテストする方法、どのメトリクスが重要か、そしてほとんどのバックテスト結果が本当とは思えないほど良い理由です。